(Q37087894)

18 August 2017

Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients (English)

1 reference

18 August 2017

0 references

1 reference

Robert Provenzano

1

1 reference

18 August 2017

Brigitte Schiller

2

1 reference

18 August 2017

Madhumathi Rao

3

1 reference

18 August 2017

Daniel Coyne

4

1 reference

18 August 2017

Louis Brenner

5

1 reference

18 August 2017

Brian J G Pereira

6

1 reference

18 August 2017

28 January 2009

1 reference

Clinical Journal of the American Society of Nephrology

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

2

1 reference

18 August 2017

386-393

1 reference

Ferumoxytol for treating iron deficiency anemia in CKD

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Resolving the paradigm crisis in intravenous iron and erythropoietin management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Iron requirements in erythropoietin therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Labile iron in parenteral iron formulations: a quantitative and comparative study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Strategies for iron supplementation: oral versus intravenous

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

A randomized controlled study of iron supplementation in patients treated with erythropoietin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

The safety of intravenous iron dextran in hemodialysis patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Low-molecular-weight protein-permeable cuprammonium rayon haemofilter

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Iron management in end-stage renal disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Iron status and hemoglobin level in chronic renal insufficiency

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2637590

Safety of ferumoxytol in patients with anemia and CKD

3 September 2018

1 reference

12 December 2020

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

12 December 2020

Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium

1 reference

12 December 2020

Structure, chemistry, and pharmacokinetics of intravenous iron agents

1 reference

12 December 2020

Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections

1 reference

12 December 2020

The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients

1 reference

12 December 2020

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study

1 reference

12 December 2020

Role of oral iron in the management of long-term hemodialysis patients

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.02840608

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19176796

1 reference